Your browser doesn't support javascript.
loading
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.
Htoo, Phyo T; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J; Everett, Brendan M; Glynn, Robert J; Schmedt, Niklas; Koeneman, Lisette; Déruaz-Luyet, Anouk; Paik, Julie M; Patorno, Elisabetta.
Afiliación
  • Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.
  • Tesfaye H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.
  • Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.
  • Wexler DJ; Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, USA.
  • Everett BM; Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Glynn RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.
  • Schmedt N; Global Epidemiology, Boehringer Ingelheim International GmbH (Germany) DE, Berlin, Germany.
  • Koeneman L; Global Medical Affairs, Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Déruaz-Luyet A; Global Epidemiology, Boehringer Ingelheim International GmbH (Germany) DE, Berlin, Germany.
  • Paik JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.
  • Patorno E; Division of Renal (Kidney) Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Cardiovasc Diabetol ; 23(1): 103, 2024 Mar 18.
Article en En | MEDLINE | ID: mdl-38500096

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos